IGC Pharma, Inc. — Major Shareholding Notification 2011

Jan 31, 2011

SC 13G/A 1 c11638sc13gza.htm SC 13G/A sc13gza PAGEBREAK

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934 (Amendment No. 2)*

India Globalization Capital Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

45408X100

(CUSIP Number)

December 31, 2010

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

þ Rule 13d-1(b)

o Rule 13d-1(c)

o Rule 13d-1(d)

• The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

PAGEBREAK

CUSIP No. 45408X100

1	NAMES OF REPORTING PERSONS UBS AG directly and on behalf of certain subsidiaries
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Switzerland
	5	SOLE VOTING POWER
NUMBER OF		855,242
SHARES	6	SHARED VOTING POWER
BENEFICIALLY
OWNED BY		0
EACH	7	SOLE DISPOSITIVE POWER
REPORTING
PERSON		855,242
WITH:	8	SHARED DISPOSITIVE POWER
		0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	855,242
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	o
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	5.91%
12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	BK

Page 2 of 5

PAGEBREAK

CUSIP No. 45408X100

Item 1(a)	Name of Issuer
	India Globalization Capital Inc
Item 1(b)	Address of Issuer’s Principal Executive Offices:
	4336 Montgomery Ave.
	Bethesda, Maryland 20814
Item 2(a)	Name of Person Filing:
	UBS AG
Item 2(b)	Address of Principal Business Office:
	UBS AG
	Bahnhofstrasse 45
	PO Box CH-8021
	Zurich, Switzerland
Item 2(c)	Citizenship or Place of Organization:
	Switzerland
Item 2(d)	Title of Class of Securities
	Common Stock
Item 2(e)	CUSIP Number(s):
	45408X100
Item 3.	Type of Person Filing:
	UBS AG is classified as a Bank as defined in section 3(a)(6) of the
Securities Act or 1933 pursuant to no-action relief granted by the staff of
the Securities and Exchange Commission.
Item 4 (a)-(c)(iv).	Ownership:
	Items 5-11 of the cover page are incorporated by reference.

Folio Page 3 of 5 /Folio

PAGEBREAK

CUSIP No. 45408X100

Item 5.	Ownership of Five Percent or Less of a Class:
	If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following o .
Item 6.	Ownership of More than Five Percent on Behalf of Another Person:
	Not applicable
Item 7.	Identification and Classification of the Subsidiary That Acquired the
Security Being Reported on By the Parent Holding Company:
	This statement on Schedule 13G is being filed by UBS AG on behalf of itself
and its wholly owned subsidiary UBS Securities LLC.
Item 8.	Identification and Classification of Members of the Group
	Not Applicable
Item 9	Notice of Dissolution of Group:
	Not Applicable
Item 10.	Certification:
	By signing below, the undersigned certify that, to the best of their
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that
purpose or effect.

Folio Page 4 of 5 /Folio

PAGEBREAK

CUSIP No. 45408X100

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

By:	/s/ Anthony DeFilippis
	Executive Director
By:	/s/ Gordon Kiesling
	Executive Director

Date: January 31, 2011

Folio Page 5 of 5 /Folio